Data from the UALCAN portal (https://ualcan.path.uab.edu, accessed on 25 June 2023) showed that the expression levels of CXCL17 and GPR35 in AML cells do not influence patient outcomes [8,10]. Here, CXCL17 is linked to acute myeloid leukemia.